comparemela.com

Latest Breaking News On - Marc stapley - Page 1 : comparemela.com

Glaukos (NYSE:GKOS) Hits New 12-Month High at $115.10

Glaukos (NYSE:GKOS) Hits New 12-Month High at $115.10
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Alger
Algeria
Gilberth-kliman
Stifel-nicolaus
Marc-stapley
Jpmorgan-chase-co
Brown-capital-management
Fred-alger-management
Dimensional-fund-advisors
Needham-company
Glaukos-co
Vanguard-group-inc

Citigroup Increases Glaukos (NYSE:GKOS) Price Target to $130.00

Glaukos (NYSE:GKOS – Free Report) had its target price boosted by Citigroup from $120.00 to $130.00 in a research note released on Wednesday morning, Benzinga reports. The brokerage currently has a buy rating on the medical instruments supplier’s stock. Several other analysts have also issued reports on GKOS. JPMorgan Chase & Co. boosted their price […]

Alexr-thurman
Marc-stapley
Glaukos-corporation
Cetera-advisors
Citigroup
Bellevue-group
Securities-exchange-commission
Jefferies-financial-group
Needham-company
Magnetar-financial
Jpmorgan-chase-co
Free-report

Veracyte, Inc. (NASDAQ:VCYT) Q1 2024 Earnings Call Transcript

Veracyte, Inc. (NASDAQ:VCYT) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United-states
American
Mason-carrico
William-blair
Marc-stapley
Ji-nam
Rebecca-chambers
Shayla-gorman
Andrew-brackmann
Biggest-real-estate-companies
Scotiabank
Exchange-commission

Glaukos (NYSE:GKOS) Stock Rating Lowered by StockNews.com

Glaukos (NYSE:GKOS – Get Free Report) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Tuesday. Other equities analysts also recently issued reports about the company. Morgan Stanley started coverage on Glaukos in a report on Monday, December 4th. They set an “equal weight” rating and […]

Canada
Josephe-gilliam
Piper-sandler
Marc-stapley
Morgan-stanley
Securities-exchange-commission
Wells-fargo-company
Glaukos-corporation
Glaukos-company-profile
National-bank
Silverarc-capital-management
Quadrant-capital-group

Wells Fargo & Company Boosts Glaukos (NYSE:GKOS) Price Target to $103.00

Glaukos (NYSE:GKOS – Free Report) had its price objective hoisted by Wells Fargo & Company from $83.00 to $103.00 in a research report report published on Thursday morning, Benzinga reports. They currently have an overweight rating on the medical instruments supplier’s stock. A number of other equities analysts have also recently weighed in on the […]

Marc-stapley
Piper-sandler
Josephe-gilliam
Lisanti-capital-growth
Wells-fargo-company
Glaukos-company-profile
Morgan-stanley
Glaukos-corporation
Wealthcare-advisory-partners
Needham-company
Charles-schwab-investment-management-inc
Free-report

vimarsana © 2020. All Rights Reserved.